CLINICAL_TRIALS
trial_result
· 2012-12-03
Clinical Trial Update: A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 2]
Summary
A Phase II double-blind trial of KPS-0373 in Spinocerebellar degeneration has completed. The study identifier is NCT01384435.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: SCD | Phase 2 | Status: COMPLETED